David W. Dodick, M.D., FAHS

Professor (Emeritus), Mayo Clinic
Consultant, Mayo Clinic International
Chair, Atria Academy of Science and Medicine
New York, NY

LEARNING OBJECTIVES
At the conclusion of the session, you will be better able to:

• Evaluate the potential role of novel agents in migraine prevention
• Highlight recent data on the efficacy and safety of treatments for migraine prevention
• Address key questions around the clinical application of migraine prevention therapy